110 results
Page 2 of 6
6-K
EX-10.1
48pv7er1 xv4foamr6c6
25 Sep 20
Current report (foreign)
4:33pm
6-K
EX-99
2qdvcnzzph1 5hznqen
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
EX-99
ubh0b8434d0 x29v
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
97shlq1h
28 May 20
Current report (foreign)
11:56am
6-K
EX-1
ify6o
28 May 19
Current report (foreign)
7:04am
6-K
EX-99
kxxlxvy64inypf6gz0v
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99.1
er1o6mgei073
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
1ciug bfh3u
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
5s37hep
5 Feb 19
BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
9:00am
6-K
EX-99.2
wq2qfi
4 Feb 19
Current report (foreign)
4:30pm
6-K
EX-10.2
kvz 4ljxxwpofr
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.3
5qwjp9xz
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am